BACKGROUND: There is growing evidence that inhalants are neurotoxic to white matter, yet limited work has been conducted to investigate the neurobiologic effects of long-term exposure among adolescent users, despite inhalant use being most prominent during this developmental period. METHODS: We used diffusion tensor imaging to examine white-matter integrity in 11 adolescents who used inhalants, 11 matched cannabis users and 8 drug-naive controls. RESULTS: Although both groups of drug users had white-matter abnormalities (i.e., lower fractional anisotropy), abnormalities were more pronounced in the inhalant group, particularly among early-onset users. LIMITATIONS: The findings of this study should be considered in light of its small sample size, cross-sectional design and the complex psychosocial background of long-term inhalant users. CONCLUSION: White-matter abnormalities may underpin long-term behavioural and mental health problems seen in individuals with long-term inhalant use.
BACKGROUND: There is growing evidence that inhalants are neurotoxic to white matter, yet limited work has been conducted to investigate the neurobiologic effects of long-term exposure among adolescent users, despite inhalant use being most prominent during this developmental period. METHODS: We used diffusion tensor imaging to examine white-matter integrity in 11 adolescents who used inhalants, 11 matched cannabis users and 8 drug-naive controls. RESULTS: Although both groups of drug users had white-matter abnormalities (i.e., lower fractional anisotropy), abnormalities were more pronounced in the inhalant group, particularly among early-onset users. LIMITATIONS: The findings of this study should be considered in light of its small sample size, cross-sectional design and the complex psychosocial background of long-term inhalant users. CONCLUSION:White-matter abnormalities may underpin long-term behavioural and mental health problems seen in individuals with long-term inhalant use.
Authors: Wynne K Schiffer; Dianne E Lee; David L Alexoff; Rich Ferrieri; Jonathan D Brodie; Stephen L Dewey Journal: Psychopharmacology (Berl) Date: 2006-04-22 Impact factor: 4.530
Authors: N L Rosenberg; B K Kleinschmidt-DeMasters; K A Davis; J N Dreisbach; J T Hormes; C M Filley Journal: Ann Neurol Date: 1988-06 Impact factor: 10.422
Authors: Stephen M Smith; Mark Jenkinson; Heidi Johansen-Berg; Daniel Rueckert; Thomas E Nichols; Clare E Mackay; Kate E Watkins; Olga Ciccarelli; M Zaheer Cader; Paul M Matthews; Timothy E J Behrens Journal: Neuroimage Date: 2006-04-19 Impact factor: 6.556
Authors: Nadia Solowij; Katy A Jones; Megan E Rozman; Sasha M Davis; Joseph Ciarrochi; Patrick C L Heaven; Nicole Pesa; Dan I Lubman; Murat Yücel Journal: Psychopharmacology (Berl) Date: 2011-09-21 Impact factor: 4.530
Authors: Zukhrofi Muzar; Reymundo Lozano; Andrea Schneider; Patrick E Adams; Sultana M H Faradz; Flora Tassone; Randi J Hagerman Journal: Am J Med Genet A Date: 2015-04-21 Impact factor: 2.802
Authors: Marisa M Silveri; Alecia D Dager; Julia E Cohen-Gilbert; Jennifer T Sneider Journal: Neurosci Biobehav Rev Date: 2016-07-01 Impact factor: 8.989